%D8%A7%D9%84%D8%AA%D9%87%D8%A7%D8%A8_%D9%83%D8%A8%D9%8A%D8%A8%D8%A7%D8%AA_%D8%A7%D9%84%D9%83%D9%84%D9%89GlomerulonefritisGlomerulonefritisGlomerulonephritisGlomerulonephritisGlomerulonefritisGlomerulonefriitGlomerulonefritis%DA%AF%D9%84%D9%88%D9%85%D8%B1%D9%88%D9%84%D9%88%D9%86%D9%81%D8%B1%DB%8C%D8%AAGlom%C3%A9rulon%C3%A9phriteGlomar%C3%BAlaineafra%C3%ADteasGlomerulonefrite%D7%93%D7%9C%D7%A7%D7%AA_%D7%A4%D7%A7%D7%A2%D7%99%D7%95%D7%AA_%D7%94%D7%9B%D7%9C%D7%99%D7%94Glomerulonefritis%D4%B3%D5%AC%D5%B8%D5%B4%D5%A5%D6%80%D5%B8%D6%82%D5%AC%D5%B8%D5%B6%D5%A5%D6%86%D6%80%D5%AB%D5%BFGlomerulonefritisGlomerulonefrite%E7%B3%B8%E7%90%83%E4%BD%93%E8%85%8E%E7%82%8E%D0%93%D0%BB%D0%BE%D0%BC%D0%B5%D1%80%D1%83%D0%BB%D0%BE%D0%BD%D0%B5%D1%84%D1%80%D0%B8%D1%82%EC%82%AC%EA%B5%AC%EC%B2%B4%EC%BD%A9%ED%8C%A5%EC%97%BCNefritas_(liga)GlomerulonefritisGlomerulonefrittK%C5%82%C4%99buszkowe_zapalenie_nerek%DA%AF%D9%84%D9%88%D9%85%DB%90%D8%B1%D9%88%D9%84%D9%88%D9%86%DB%90%D9%81%D8%B1%D8%A7%D9%8A%D9%BC%D8%B3GlomerulonefriteGlomerulonefrit%C4%83%D0%93%D0%BB%D0%BE%D0%BC%D0%B5%D1%80%D1%83%D0%BB%D0%BE%D0%BD%D0%B5%D1%84%D1%80%D0%B8%D1%82Glomerulonefrit%C3%ADdaGlomerulonefrit%D0%93%D0%BB%D0%BE%D0%BC%D0%B5%D1%80%D1%83%D0%BB%D0%BE%D0%BD%D0%B5%D1%84%D1%80%D0%B8%D1%82GlomerulonefritQ605006
about
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA NephropathyHSP-glomerulonephritis Trial: MP vs CyAEffects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal TransplantA Dose Escalation Study of Long-acting ACTH Gel in Membranous NephropathyUrinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After PyelonephritisCalcitriol in the Treatment of Immunoglobulin A NephropathyUsing the Drug Spironolactone to Test If It Reduces Protein Leakage From the KidneyTacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)Phase II Study Assessing Safety and Efficacy of APL-2 in GlomerulopathiesNon-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 StudyGrazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic NephropathyRituximab in Refractory Primary Membranous NephropathyEculizumab Therapy for Dense Deposit Disease and C3 NephropathyInhibitors of Angiotensin II in Proteinuric Mesangioproliferative GlomerulonephritisEfficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous NephropathyRituximab Plus Cyclosporine in Idiopathic Membranous NephropathyRituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous NephropathyMesenchymal Stromal Cells (MSC´s) in Renal LupusRepository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)Eculizumab in Primary MPGNEfficacy and Safety of Shenyankangfu Tablets for Primary GlomerulonephritisEfficacy and Safety of Losartan in Children With Ig A NephropathyPilot Study of Rituximab to Treat Fibrillary GlomerulonephritisACTHAR GEL in Patients With Membranous (Class V) Lupus NephritisClinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit DiseaseA Study of Belimumab in Idiopathic Membranous GlomerulonephropathyA Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA NephropathyAldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney DiseaseStudy of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic NephropathyMycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis (IMG)Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without GlomerulonephritisEffect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With CystinuriaStudy on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not TransplantedThe Canadian Glomerulonephritis Registry and Translational Research InitiativeA Proof of Concept Study for a 12 Month Treatment in Patients With C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)A Proof of Concept Study for 6 Month Treatment in Patients With C3 Glomerulopathy (C3G)Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1Autonomic Nervous System (ANS) and Renal Function in Immunoglobin A (IgA) Nephropathy
P1050
P2175
IgA glomerulonephritisacute poststreptococcal glomerulonephritisfibrillary glomerulonephritisrapidly progressive glomerulonephritisacute proliferative glomerulonephritislupus nephritismembranous glomerulonephritischronic rapidly progressive glomerulonephritisexudative glomerulonephritisproliferative glomerulonephritisfocal embolic glomerulonephritisdiffuse glomerulonephritissubacute glomerulonephritisimmune-complex glomerulonephritismembranoproliferative glomerulonephritismesangial proliferative glomerulonephritisEndocapillary proliferative glomerulonephritisautoimmune glomerulonephritisglomerulosclerosisimmunotactoid glomerulopathyMinimal mesangial glomerulonephritisPulmonary-renal syndrome
P279
Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN)Successful recovery of infective endocarditis-induced rapidly progressive glomerulonephritis by steroid therapy combined with antibiotics: a case reportSilica and glomerulonephritis: case report and review of the literatureWT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosisp38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritisMembranoproliferative glomerulonephritis associated with a mutation in Wilms' tumour suppressor gene 1Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in miceIdentification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritisEculizumab for dense deposit disease and C3 glomerulonephritisA case of post-streptococcal glomerulonephritis with diffuse alveolar hemorrhageMembrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndromeFactor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient miceVariations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritisFamilial glomerulonephritis in Doberman pinscher dogsBright's disease today: the pathogenesis and treatment of glomerulonephritis--IInterleukin-10 inhibits experimental mesangial proliferative glomerulonephritisNephrotic glomerulonephritisExperimental glomerulonephritis induced by hydrocarbon exposure: a systematic reviewIgA glomerulonephritis in a plumber working with solvent-based pipe cementThe Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western CountriesReclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GNEvidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014Hypertension in Chronic GlomerulonephritisPauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated VasculitisGlomerular diseases and cancer: evaluation of underlying malignancy.Hepatitis C virus-related mixed cryoglobulinemic endocapillary proliferative glomerulonephritis and B-cell non-Hodgkin lymphoma: a case report and literature reviewMyeloperoxidase anti-cytoplasmic antibody related crescentic glomerulonephritis in a patient with IgG3λ monoclonal immunoglobulin deposition disease with membranous featuresThe role of myeloperoxidase and myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCAs) in the pathogenesis of human MPO-ANCA-associated glomerulonephritisDe novo membranoproliferative glomerulonephritis III in a renal transplant patient: case report and review of the literatureSevere hypoalphalipoproteinaemia in a child with acute post-streptococcal glomerulonephritis (APSGN)Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusionSuccessful delivery in a patient with antineutrophil cytoplasmic antibody-associated glomerulonephritisThe glomerulopathy of sickle cell diseaseNovel Role of Toll-Like Receptor 3 in Hepatitis C-Associated GlomerulonephritisAntineutrophil cytoplasm antibody in crescentic glomerulonephritisArteritis in a novel congenic strain of mice derived from MRL/Lpr lupus mice: genetic dissociation from glomerulonephritis and limited autoantibody productionAnti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitisA novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelia
P921
Q61921440-1F61A5C0-083D-498C-AB6E-AB7DE2473A43Q61921491-99A2A6A4-57D3-485F-ABF8-77A9505F38C7Q61924426-BEBEB1F4-06A8-4E3D-8CDE-DCE1E63B7BE5Q61924454-DA149BE7-2D82-4650-8C1C-3B43821F16CEQ61936908-65E80A74-8D58-4DF2-A05E-3C188097B15EQ61980825-9FDA3B58-6DCF-45DF-91E8-20DD57B98119Q61981301-B7CAD85A-EA1B-4AEE-9AF6-F01D141E0615Q62105693-4F037AAA-52E8-4C98-B5BC-8E8AF8F1BFF8Q63229746-944B1C34-19F4-428C-A237-E8C5621EA75EQ63316809-290FA7C0-243F-473F-9954-EB3D10712881Q63400590-8DF89555-84F1-4E69-BD91-6227CDACE0F3Q63598037-18D37764-0496-421C-845B-72DDE030DBAFQ63613533-D462507D-C2E6-4994-980D-6D96572EA575Q63808186-C471519D-1A0F-4C06-B053-EE5D29BA3D04Q63817687-30FB75F4-EC6F-4622-920A-E013A92BEE70Q63831781-3B9B7A68-617C-4787-BD16-BDC68EECFA14Q63845088-BCB00513-A7B9-4BCF-BF99-3F805B3219CBQ64123652-649B68B3-3006-4678-B911-C49BFC56080CQ64150016-E388AFB3-EFC3-42CC-A1B8-1F9308EA5394Q64173195-1AC5DFCB-3F24-481D-BD43-AA44A8F34419Q64185311-E56804DE-F5BA-4B6C-996D-836EFB4B31E9Q64220445-41F48243-7C65-451D-9D03-9FD2F3ED8001Q64223277-6D96C42F-8FE7-4BAB-A177-393C31F6C2D8Q64607184-ECB8CD39-9314-4B46-B5BB-88E580319D1AQ64609766-4113C64F-9858-4700-AE15-879F19662DDEQ64621542-1CD59AAD-34F5-4E93-A2A6-516F182B6A0FQ64634950-D0B27C07-4F6B-43CA-9919-F597FD3AA068Q64645092-CF8699CF-206D-4986-B198-239A69045521Q64654045-F85A3AAE-0A15-40F9-A85A-89B8E230A4B5Q64655254-6ECF365F-A2A8-4B02-A96F-EDB0CB6A0AC9Q64677702-09A5A532-9882-468B-9DD0-1A9F9A34BC81Q64681187-8B11AAA0-B35D-40C7-B820-7C078D562B60Q64695405-4353C012-45D1-479D-A964-CFC41B558D8EQ64792022-4A753682-B303-44DF-B1E4-6F5C24A7A1BAQ64792592-180B6407-A0D7-4EF1-ADC3-E5480BFB3DEFQ64801936-44E3420B-0DC7-4FCC-92DA-31B9C6030FF7Q64802024-95A09196-7592-42A2-AAAE-095C18358870Q64806679-1C6AFC2C-140E-4248-82B6-7FDA66A0ABD7Q64807892-B32D5B40-AE13-4711-BBCD-E8B2942493AEQ65336200-5E5E446E-1EBE-434E-B3E8-A3B3438FB645
P1050
Q1146454-4EEB4207-879A-4BC9-A447-442942A824E9Q12097250-816777EB-BB27-4561-8189-07771258FB20Q1410776-01ca923c-4291-3f69-3fde-b20e1f38679cQ1509367-11DDAC62-CB38-42EF-9D0F-814A154BCEF2Q1538490-F2C660C4-0684-4CC2-A85B-D1350337FBB5Q1621830-8f01f7ea-42d2-073a-2842-704e70fe95cdQ1713037-3DE04AD4-C949-421E-8D4C-CD64EF32C89BQ18553997-67D5189A-F4D5-4435-98B4-870289141AE0Q18556473-C758A2D5-0962-4C22-8B4D-488842A75E3BQ18556474-FF0A2D74-741C-48B6-8852-A3A014C7D3FFQ18556475-F3AB52A7-471F-4955-9015-D5E961426BD4Q18556477-AE0CFED7-5D7E-4FB7-94BF-3991BA6007F4Q18556478-78AE84F4-1A1D-4DDC-8C67-C74513FFBCE5Q18556480-2087B620-2A8B-49CE-8382-45D904D15180Q2299379-684E5A66-6FF6-4BC3-AD09-FCC3B1DC3A62Q3772406-0FE91F06-924D-47C1-9D01-2A51BE2AF5B0Q5376224-a0dfaba4-4dc5-7857-cdc2-87b125d1c381Q55009191-f6da3700-4226-a67b-3279-bd90978ee2d8Q5571239-6DD7404B-8342-4915-AAC0-8E9180AC0328Q55789035-cedf5b86-4232-5d48-5849-b3869176d108Q6865321-d735960b-4b6e-325e-6fc8-18b9a887460fQ7259514-a18c5458-4383-d28d-190f-53a7638bea24
P279
description
Gehienbat giltzurrun-glomeruluak kaltetuak gertatzen diren nefritis-barietatea
@eu
Krankheit der Nieren
@de
malattia del rene
@it
nephritis that causes inflammation of the glomeruli located in kidney
@en
zánětlivé onemocnění glomerulů
@cs
բնութագրվում է կծիկների և մանր անոթների ախտահարմամբ
@hy
مصطلح يُستخدم للإشارة إلى عدة ...... بالكليتين ومن هنا جاءت التسمية
@ar
name
Glomarúlaineafraíteas
@ga
Glomerulonefriit
@et
Glomerulonefrit
@uz
Glomerulonefrite
@gl
Glomerulonefritis
@da
Glomerulonefritis
@eu
Glomerulonefritis
@hr
Glomerulonefritis
@id
Glomerulonefritis
@nl
Glomerulonefritída
@sk
type
label
Glomarúlaineafraíteas
@ga
Glomerulonefriit
@et
Glomerulonefrit
@uz
Glomerulonefrite
@gl
Glomerulonefritis
@da
Glomerulonefritis
@eu
Glomerulonefritis
@hr
Glomerulonefritis
@id
Glomerulonefritis
@nl
Glomerulonefritída
@sk
altLabel
(glomerulonephritis)
@sv
Brights sjukdom
@sv
Choroba Brighta
@pl
Glomerulite
@pt
Glomerulonefrites
@pt
Glomerulonephritis
@sv
Glomerulonephrititis
@sk
Glomerulopatia
@pt
Immunkomplex-Nephritis
@de
Kronisk glomerulonefrit
@sv
prefLabel
Glomarúlaineafraíteas
@ga
Glomerulonefriit
@et
Glomerulonefrit
@uz
Glomerulonefrite
@gl
Glomerulonefritis
@da
Glomerulonefritis
@eu
Glomerulonefritis
@hr
Glomerulonefritis
@id
Glomerulonefritis
@nl
Glomerulonefritída
@sk
P2888
P2581
P486
P508
P6366
P646
P1296
P1417
topic/chronic-glomerulonephritis
P1461
Glomerulonephritis-(GN)